Skip to main content
. Author manuscript; available in PMC: 2023 Nov 1.
Published in final edited form as: Microvasc Res. 2022 Aug 12;144:104421. doi: 10.1016/j.mvr.2022.104421

Table 1.

Participant Characteristics

Mean ± SD (min-max) Healthy Control (n=8) Endometriosis (n=8)
Age (yrs) 33 ± 9 (20–48) 34 ± 9 (21–45)
Height (in) 65 ± 2 (62–68) 66 ± 2 (64–69)
Weight (kg) 65 ± 10 (53–84) 70 ± 17 (52–101)
BMI (kg/m2) 28 ± 11 (20–28) 25 ± 6 (19–36)
SBP (mmHg) 111 ± 8 (101–124) 111 ± 13 (96–135)
DBP (mmHg) 73 ± 7 (60–86) 69 ± 11 (58–88)
MAP (mmHg) 86 ± 7 (74–99) 83 ± 11 (71–104)
HbA1c (%) 5.1 ± 0.27 (4.8–5.6) 4.8 ± 0.3 (4.3–5.3)
Total CHO (mg/dL) 155 ± 12 (115–222) 168 ± 30 (132–230)
HDL (mg/dL) 55 ± 4 (45–78) 54 ± 8 (41–64)
LDL (mg/dL) 89 ± 10 (52–139) 95 ± 27 (69–155)
Comorbidities
Elevated blood pressure 1 0
Stage 1 Hypertension 1 2
Hypercholesterolemia 0 1
Medications
OCP 1 2
IUD 0 1
Menstrual Cycle Status
Regular Cycles 8 3
Irregular Cycles 0 2
Partial hysterectomy (has ovaries) 0 1
Full hysterectomy (no cervix/uterus) 0 1

BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; MAP, mean arterial pressure; CHO, cholesterol; HDL, high density lipoprotein cholesterol; LDL, low density lipoprotein cholesterol; OCP, oral contraceptive; IUD, intrauterine device. Data are mean ± standard deviation (minimum-maximum)